Pertuzumab (P) with trastuzumab (T) and chemotherapy (CTX) in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction (GEJ) cancer: An international phase III study (JACOB)

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTABERNERO, Josep
dc.contributor.authorHOFF, Paulo Marcelo
dc.contributor.authorSHEN, Lin
dc.contributor.authorOHTSU, Atsushi
dc.contributor.authorYU, Ron
dc.contributor.authorENG-WONG, Jennifer
dc.contributor.authorKANG, Yoon-Koo
dc.date.accessioned2014-11-26T16:20:15Z
dc.date.available2014-11-26T16:20:15Z
dc.date.issued2013
dc.description.conferencedateMAY 31-JUN 04, 2013
dc.description.conferencelocalChicago, IL
dc.description.conferencenameAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
dc.description.indexMEDLINE
dc.identifier.citationJOURNAL OF CLINICAL ONCOLOGY, v.31, n.15, suppl.S, 2013
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/8065
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJournal of Clinical Oncology
dc.rightsopenAccess
dc.rights.holderCopyright AMER SOC CLINICAL ONCOLOGY
dc.subject.wosOncology
dc.titlePertuzumab (P) with trastuzumab (T) and chemotherapy (CTX) in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction (GEJ) cancer: An international phase III study (JACOB)
dc.typeconferenceObject
dc.type.categorymeeting abstract
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.contributor.author-fmusphcPAULO MARCELO GEHM HOFF
hcfmusp.description.issue15
hcfmusp.description.issuesuppl S
hcfmusp.description.volume31
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000335419605434
hcfmusp.publisher.cityALEXANDRIA
hcfmusp.publisher.countryUSA
relation.isAuthorOfPublication706efa42-09fc-4065-8330-9391f2cbe840
relation.isAuthorOfPublication.latestForDiscovery706efa42-09fc-4065-8330-9391f2cbe840
Arquivos